Heterogeneous Condition of Asthmatic Children Patients: A Narrative Review

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology
• Environmental Health

Background:

• Childhood asthma is a prevalent chronic disorder with diverse phenotypes, influenced by genetics, age, severity, and comorbidities.
• Current treatments primarily target the type 2 (T2) inflammatory pathway, involving IL-4, IL-5, and IL-13.
• Despite advancements, improving pediatric asthma outcomes and personalizing treatment remain significant challenges.

Purpose of the Study:

• To review the current landscape of pediatric asthma, highlighting unmet needs and future directions.
• To emphasize the need for novel biomarkers for improved patient stratification and treatment selection.
• To discuss the impact of global challenges like climate change and pandemics on childhood asthma.

Main Methods:

• Literature review and synthesis of current research on pediatric asthma phenotypes, treatments, and outcomes.
• Analysis of the role of T2 inflammation and the need for new biomarkers.
• Discussion of environmental factors and emerging health crises affecting asthma management.

Main Results:

• Pediatric asthma is a heterogeneous condition, not a single disease, necessitating individualized approaches.
• There is a critical need for predictive biomarkers to guide therapy and stratify patients.
• Allergen immunotherapy, microbiome evaluation, and targeted therapies are essential preventive and treatment strategies.

Conclusions:

• Improving pediatric asthma outcomes requires addressing disease heterogeneity and developing new biomarkers.
• Preventive and targeted therapeutic strategies are vital for this population.
• The impact of environmental factors and global health events on childhood asthma must be considered.